← Evidence map

ArticleNature nanotechnology2017

Multivalent bi-specific nanobioconjugate engager for targeted cancer immunotherapy.

Hengfeng Yuan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

68 papers cite itlatest 60 shown

2017
…
2018
2019
2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 28459470